Alternative rubber gloves win U.S. FDA approval

Key points
- People allergic to traditional rubber gloves could see relief from a new alternative made from a different type of latex approved by U.S. health regulators on Wednesday.
- The new gloves, made by privately-held Yulex Corp, are derived from a North American desert plant and aim to provide coverage without the skin itchiness and redness common to those who cannot tolerate regular latex.
- Rubber gloves - a staple among health-care workers to help prevent the spread of diseases - cause reactions in anywhere from 3 percent to 22 percent of doctors, nurses and other technicians, according to the U.S.
- The FDA said data found people with latex allergies did not have a reaction to those made from the alternative plant, the guayule bush found in the Southwestern United States.
People allergic to traditional rubber gloves could see relief from a new alternative made from a different type of latex approved by U.S. health regulators on Wednesday.
The new gloves, made by privately-held Yulex Corp, are derived from a North American desert plant and aim to provide coverage without the skin itchiness and redness common to those who cannot tolerate regular latex.
Rubber gloves - a staple among health-care workers to help prevent the spread of diseases - cause reactions in anywhere from 3 percent to 22 percent of doctors, nurses and other technicians, according to the U.S. Food and Drug Administration, which approved Yulex's gloves.
The FDA said data found people with latex allergies did not have a reaction to those made from the alternative plant, the guayule bush found in the Southwestern United States. FDA spokeswoman Karen Riley offered no more details about the data.
Like traditional rubber gloves, the new ones will also have to carry a warning about possible allergies because there have been no long-term studies on possible reactions, the FDA said.
Traditional rubber is produced using the sap of the hevea braziliensis rubber tree, but repeated or long-term exposure can trigger reactions that can also include coughing, wheezing and other breathing problems.
A spokeswoman for Yulex could not be immediately reached for comment.
The Arizona-based company has said it is investing heavily in the guayule bush, expanding operations to Australia to harvest seedlings and looking at ways to produce latex from the plant in bulk. Yulex is also exploring its use in alternative fuels and adhesives.
WASHINGTON (Reuters)
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Lungs, Asthma & Allergies →
NewsBlood test predicts severity of peanut and seafood allergies
A new blood test promises to predict which people will have severe allergic reactions to foods according to a new study led by Mount Sinai researchers and published online today in the The Annals of Allergy, Asthma &…
1 April 2015
NewsHow the human immune system keeps TB at bay
A new tissue culture model using human white blood cells shows how people with a latent - or symptom-free - tuberculosis infection are protected from active disease by a critical early step in their immune response,…
26 March 2015
NewsSpot treatment
Acne, a scourge of adolescence, may be about to meet its ultra high-tech match. By using a combination of ultrasound, gold-covered particles and lasers, researchers from UC Santa Barbara and the private medical device…
19 March 2015

